Issue 3 Articles
New Factors in Screening Colonoscopy for Colorectal Neoplasia
Colonoscopy screening for colorectal adenomatous polyps or cancer has become a worldwide recommendation since this is the third most common human cancer[1-3] resulting in an estimated 49900deaths annually[3]. Furthermore, polyps and cancers have been observed in younger people resulting in recommendations by societies to start screening at age 45 [4].
The Need of CDH1 Germline Mutation Screening in Patients with Gastric Cancer in the West
Although the international guidelines recommend the CDH1 germline mutations screening in patients at risk of carrying pathogenic mutations, few data exist about the compliance to systematic screening programs carried out in surgical centres
Quality of Life in Locally Advanced Colorectal Cancer Patients – An Extremely Multi-Layered Problem – A Systematic Review
There are quite more than dozens studies in world literature concerning the problems of the quality of life of patients with colorectal cancer in a wide variety of clinical and socio-individual aspects. It is significantly difficult any specific screening and stratified grouping of similar problems in patients with locally advanced cancerboth of the colon and rectum to be implemented
Percutaneous Endoluminal Forceps Biopsy in Cholangiocellular Carcinoma – A Perspective Approach to Timeliness of Diagnostic Confirmation Using Two Scenarios
To assess the benefits of performing endoluminal forceps biopsy during initial drainage compared to postponed biopsy using two patient management scenarios. Since 2006, 101 consecutive patients with malignant biliary stenosis due to cholangiocellular carcinoma have been followed up. All patients underwent a percutaneous biliary drainage (PBD) procedure and endoluminal forceps biopsy to obtain histological verification of stenosis
Venous Outflow Complication after Living Donor Liver Transplantation Using Right-Liver Graft without Middle Hepatic Vein
Hepatic venous outflow complications are major obstacles to success of living donor liver transplantation (LDLT), especially using a right-liver graft without the middle hepatic vein (MHV). The aim of this study wasto clarify hepatic venous outflow complication, the risk factors for hepatic venous stenosis and the role of endovascular intervention in its management in LDLT using a right-liver graft without the MHV